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Abstract Nanoinformatics has recently emerged to address the need of computing 
applications at the nano level. In this regard, the authors have participated in various 
initiatives to identify its concepts, foundations and challenges. While nanomaterials 
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open up the possibility for developing new devices in many industrial and scientific 
areas, they also offer breakthrough perspectives for the prevention, diagnosis and treat-
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ment of diseases. In this paper, we analyze the different aspects of nanoinformatics 
and suggest five research topics to help catalyze new research and development in the 
area, particularly focused on nanomedicine. We also encompass the use of informatics 
to further the biological and clinical applications of basic research in nanoscience and 
nanotechnology, and the related concept of an extended "nanotype" to coalesce infor-
mation related to nanoparticles. We suggest how nanoinformatics could accelerate 
developments in nanomedicine, similarly to what happened with the Human Genome 
and other -omics projects, on issues like exchanging modeling and simulation methods 
and tools, linking toxicity information to clinical and personal databases or developing 
new approaches for scientific ontologies, among many others. 
Keywords Nanoinformatics • Computing • Nanotechnology • Bioinformatics • 
Medical Informatics • Nanomedicine 
1 Introduction 
Over the past five decades many computing methods and applications have arisen in 
the context of biomedicine, leading to interdisciplinary areas such as medical infor-
matics, bioinformatics and others [1-3]. These biomedical-related informatics disci-
plines span a wide range of scientific and technological approaches to solve complex 
problems, including, among others, data and knowledge integration methods, biomed-
ical ontologies and vocabularies, data and text mining, systems interoperability, DNA 
and RNA sequencing, medical decision support, predicting the relationships between 
gene mutations and diseases, the development of standards for data representation and 
exchange, or the development of informatics methods and tools for integrating multi-
level data and creating multi-scale simulations of biomedical systems. Informaticians 
have successfully contributed to these areas, leading to outstanding results such as the 
Human Genome and other -omics projects, the computerization of clinical practice or 
the creation of computerized systems for decision support [4]. The authors have been 
active in informatics research supporting a number of projects in the past decades and 
pioneered significant examples such as, among others, medical expert systems [5-7]. 
After various decades of research on such biomedical systems, a challenging new 
field, nanomedicine, which promises to deliver scientific and technological break-
throughs that could transform medicine, is beginning to receive attention from the 
scientific community, including informaticians [8]. 
To our knowledge, no paper has been published, at the time of writing, in the 
computing literature about nanoinformatics. Figure 1 presents an analysis of these 
references, using the goPubmed [9] facility. 
In this context, one particular challenging issue, which remains mostly unexplored, 
is the application of computing to nanomedicine. To advance research in this field, 
requirements for data, information and knowledge management need to be specified, 
and are substantial. While research in this area is commonly associated with nanotech-
nology there are many topics where computational methods are themselves critical to 
advance research and support professional practice. For instance, we have identified 
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Fig. 1 A comparative analysis among the references available in Medline with the terms "Nanotechnol-
ogy Informatics", "Medical Informatics", "Bioinformatics" and "Biomedical Computing" carried out with 
goPubmed [9]. On the left side, is shown the number of publications per year (2000-present); on the right 
side, the top terms or most common keywords used in these publications 
various areas where significant research in informatics applied to nanomedicine is 
already underway [10,11]. These can be summarized in the following non-exhaustive 
list: 
- Nanoparticle characterization 
- Modeling and simulation 
- Imaging 
- Terminologies, ontologies and standards 
- Data Integration and Exchange 
- Systems' interoperability 
- Data and text mining for nanomedical research 
- Linking nano-information to computerized medical records 
- Basic and translational research 
- Networks of international researchers, projects and labs 
- Nanoinformatics Education 
- Ethical Issues 
Nanoinformatics has only recently emerged to address these issues, with the support of 
organizations like the US National Science Foundation, the National Cancer Institute 
and the European Commission. In this new context, (biomedical or nanomedical) nano-
informatics refers to the use of informatics techniques for analyzing and processing 
information about the structure and physico-chemical characteristics of nanoparticles 
and nanomaterials, their interaction with their environments, and their applications for 
nanomedicine [10,11]. Such new applications emerge in a time where genomic and 
personalized medicine are still getting recognition, and promise additional future per-
spectives for biomedicine. We have adopted the term "nanoinformatics" in this paper, 
as a contraction and easier form of the broader terms "biomedical nanoinformatics" or 
"nanomedical informatics". Nanoinformatics can be also related to other applications 
of nanotechnology but we will address here only biomedical applications. 
Given the rapidly advancing extensions of all the informatics issues arising between 
molecular biology and systems biology (bioinformatics and computational biol-
ogy) and public health (for public health bioinformatics) in biomedical practice and 
research, we can wonder if current informatics applications—e.g., from bioinformatics 
or medical informatics—may also be ready to address this new area of nanomedicine. 
The latter is considered by many as the new frontier of medicine—at a different, nano 
level, which implies significant physical and chemical differences—raising great chal-
lenges for research, medical practice and economic implications due to novel toxic-
therapeutic tradeoffs at the nano level [12-15]. In this regard, we might recall what 
happened around 1995-2001, when bioinformatics contributed to the early comple-
tion of the Human Genome Project, and here one can conjecture that informatics 
will also be essential to progress in the development of nanomedicine. In addition to 
new computing methods and tools, the possibilities of reusing informatics methods, 
tools, data and lessons learned may well contribute to speeding up the development 
of nanomedicine. 
Nanomedicine includes a large number of significant topics of practical and scien-
tific impact, such as, for instance, the early detection of diseases like cancer, the ability 
to reach highly specific targets within the body, new molecular imaging methods based 
on the optical properties of nanoparticles, methods to control drug delivery at very 
low dosages, nanorobots for diagnosis and therapy, and novel approaches to overcome 
solubility limitations of new or existing drugs. Readers can access a large number of 
reports for further reference [8,12-14]. 
Let us consider an example. Some of the authors (at the Universidad Politecnica de 
Madrid (UPM)) have developed an informatics application, based on text mining tech-
niques, that we have called "the nanotoxicity searcher", which automatically searches 
for toxicity information in the literature. In searches carried out for paclitaxel, infor-
mation about nanotoxicity was found, combined with appropriate ontologies—like the 
Nanoparticle Ontology [15] and others such as the Foundational Model of Anatomy 
[16]—, and it can be made available to physicians in advance of treatment or linked 
to the electronic health record. 
This research and other efforts [17-20] have raised issues associated with manag-
ing the nanotechnology information, most notably: (a) the lack of adequate standard 
classifications of nanomaterials, (b) the rapidly evolving knowledge of the many com-
plex biological, chemical and physical processes occurring at the nano level, and (c) the 
heterogeneity of the information content and structure of many scientific papers in the 
very diverse nano disciplines and subfields. All of these issues magnify the challenges 
of applying standard information extraction and retrieval methods to the literature 
without further additional knowledge of the specifics of the fields and subfields rep-
resented. New informatics approaches are needed to efficiently and effectively link 
information from nanomedicine, while addressing the various levels of complexity 
covered by research, development and translation in nanotechnology. 
In this context, the authors have worked in an international collaboration to define 
nanoinformatics and propose a roadmap for the field [18]. We present below the main 
conclusions of our analysis. 
2 A perspective for nanoinformatics applications 
In Table 1, we extend the approach we previously used to analyze biomedical infor-
matics, contrasting its medical informatics and bioinformatics components [4]. We 
now contrast nanoinformatics with informatics applications in biomedicine according 
to six different perspectives. 
We expand this comparison below. 
2.1 Academic disciplines: development and scientific goals 
A "Workshop on Nanoinformatics Strategies," supported by the National Science 
Foundation, was held in Arlington, Virginia in 2007 [17], followed by various confer-
ences. This workshop focused on practical engineering perspectives, without including 
existing computing infrastructures. Given the relatively short time since this meeting 
took place, only a few references can be found in the literature at the time of writing; 
however, an increasing number of web references show that nanoinformatics is evolv-
ing rapidly. Since nanotechnology is involved in issues beyond medical and biological 
domains, we can anticipate how the use of nanomaterials may have an impact on health 
issues. 
2.2 Scientific content and informatics goals 
The past decade has seen considerable efforts to correlate molecular and clinical 
data for scientific discovery, which have led to significant achievements. However, 
the semantic heterogeneity, the inherent complexity and uncertainty associated with 
linking information from these disparate biological levels has demonstrated the diffi-
culties in fulfilling the original expectations of the application of -omics information 
and knowledge to clinical practice and prognosis [21,22]. With nanomedicine, these 
difficulties can be expected to increase, but their promise is also great. 
From a scientific perspective, very distinctive quantum effects and size-related phe-
nomena take place at the nanoscale. In nanoscience, physicists and chemists have 
Table 1 Feature comparison and contrast between informatics applications in biomedicine and 
nanoinformatics 
Discipline features or 
dimensions 
Feature comparison and contrast 
Informatics applications in bio-
medicine 
Nanoinformatics applications 
1. Academic discipline, level 
of development and 
interdisciplinary links 
2. Scientific content and 
informatics goals 
3. Integrating data and 
knowledge: quality, 
availability and collection 
of data, networks, 
databases, interoperability, 
semantic issues, 
standardization and 
information retrieval 
i Increasing number of 
professionals and journals 
dedicated to the area 
i Synergy has proved 
beneficial for both medical 
informatics and 
bioinformatics 
i Need to link and integrate 
molecular, cellular and 
clinical data for scientific 
discovery. 
i Genomic medicine and 
personalized medicine more 
complicated than expected, 
but results raise great 
expectations 
i The term "Information" at 
the core of biomedical 
informatics and its 
name—however, still 
lacking a 
biologically-focused 
information theory 
i Optimally biomedical 
informatics will translate 
basic research into 
personalized medical 
advice for patients 
i Many specialized public 
databases, few with clinical 
data 
i Recent proposal: 2007 
(USA and Europe). An area 
still awaiting definition, 
with two possible 
directions: (a) as part of the 
continuum within the 
spectrum of biomedical 
engineering or biomedical 
informatics or (b) towards a 
computing discipline, 
deeply anchored in 
chemistry and physics 
i Differences at the biological 
nano level suggest that BMI 
approaches will have to be 
modified—e.g., ontologies, 
data integration, simulation 
i Challenges in basic research 
(nanoscience) might lead to 
applications in clinical 
medicine—research on 
areas like nanoparticles for 
imaging, targeting or drug 
delivery. 
i Is there a niche for 
translational research, from 
basic nanotechnology to 
nanomedical applications? 
i Clinical trials of 
nanoparticles include issues 
of security and patient 
safety 
Table 1 continued 
Discipline features 
or dimensions 
Feature comparison and contrast 
Informatics applications in 
biomedicine 
Nanoinformatics applications 
4. Tools to support 
professional practice 
5. Methods and tools to 
support research: signal 
processing, imaging and 
visualization, modeling 
i Classical standards updated 
to integrate genomic 
information 
i Large ontological initiatives 
and collaborative 
bioportals. 
i Text mining used to capture 
knowledge from medical 
sources. 
i Challenges to link 
information from the 
genotype to phenotype 
i Many recent proposals for 
low-cost electronic health 
records, with data shared by 
patients and organizations, 
facing security and privacy 
issues 
i Significant successes, still 
needing wider acceptance 
by professionals 
i Increasing costs of new 
preventive approaches 
(biomarkers, routine 
genome sequencing, etc., 
for genomic medicine) may 
be a burden for national 
health systems. 
i Early genetic detection may 
improve (or threaten?) the 
lives of citizens—ethical 
issues 
i Economic and social needs 
demand new 
approaches—small number 
of open source tools in 
clinical practice, compared 
to bioinformatics 
i 3-D image processing and 
graphic visualization, from 
molecular structures to the 
whole body for scientific 
research—e.g., the 
> New validated standard 
methods needed 
> Leverage existing 
databases, ontologies and 
tools 
> Create and administer 
massively large 
public/private datasets and 
infrastructures (like 
caNanoLAB) or build the 
tools for interoperability. 
> Metadata and annotations 
are nuanced by namespace 
> Nanosurgery and nanobots: 
futuristic scientific 
challenge 
> Prevention: 
nanobiomarkers, 
nanoparticles for disease 
detection 
> Open information 
management tools needed 
> Nanotechnology research 
very expensive, but 
nanoinformatics requires 
limited funding 
> Enormous commercial 
prospects 
> Proprietary issues—e.g., 
nanoparticles 
> Nanoparticles for new 
imaging methods 
Table 1 continued 
Discipline Features 
or Dimensions 
Feature comparison and contrast 
Informatics applications in 
biomedicine 
Nanoinformatics applications 
6. Education and training MI 
and BI professionals: Role 
as scientists, engineers and 
information brokers 
European Virtual 
Physiological Human and 
US initiatives on integrative 
physiology 
• NLM's Centers for 
Biomedical Computing 
addressing challenging 
areas 
< Many MSc and PhD 
programs focused on an 
interdisciplinary 
approaches 
i E-learning tools, also 
applied for education in 
developing countries 
i Experts in both 
areas—basic science and 
clinical practice—needed to 
act as information brokers. 
i Modeling, simulation 
(nanoHUB: a Web-based 
pool of nano resources) and 
characterization of 
nanoparticles 
i Open data and tools still 
scarce 
i No current nanoinformatics 
programs, could be created 
based on BMI experiences 
and lessons learned 
i Informatics tools will help 
professionals to address an 
extremely wide scope 
(including chemistry and 
physics) 
shown that bridging orders of magnitude in scale introduces additional scientific 
challenges. Although the basic quantum laws of physics required at the nanoscale 
are well known, additional models and tools are needed to compute the interactions 
between nanoparticles and biomolecules and to compare the results from these mod-
els with experimental measurements. For instance, research on quantum dots or the 
development of new nanoparticles for drug delivery benefit from new data, informa-
tion, theory and models of the changes in physical characteristics of materials at the 
nanoscale versus in bulk, that were not previously available or known. In this context, 
many molecular tools in use for bioinformatics cannot be directly applied—while 
others can—, and as a result substantial contributions from the field of multi-scale 
modeling and simulation holds the promise of expanding the scope of biomedical 
engineering and informatics—in areas such as imaging. 
2.3 Integrating data and knowledge 
Structuring information in nanomedicine is essential for advancing research. The term 
"nanoparticle" was introduced in 2007 [23] in MeSH, the controlled vocabulary used 
in Pubmed for organizing and indexing the biomedical literature. New taxonomies 
and ontologies, such as the Nanomedicine Taxonomy (NT) [24] and the Nanoparticle 
Ontology (NPO) [15], have been developed. Other initiatives include an ontology for 
discovery of new nanomaterials, the Nanotech Index Ontology, as well as the adoption 
of applications such as BiomedGT to map among different ontologies [19]. Efforts 
like the NPO can contribute to data collection, information classification, search and 
retrieval, data and text mining. By annotating nanoparticles, professionals can access 
information from previous research and discover knowledge that might reside in such 
information. Such work can expand the scope of biomedical ontologies—like those 
included in the Open Biological and Biomedical Ontologies (OBO) Foundry [25]. 
2.4 Tools to support professional practice 
Selection of nanomaterials for medical diagnosis and therapy should be based on cri-
teria such as size, shape, topology, composition, pharmacokinetics, biologic activity 
or toxicity. The nanoinformatics methods and tools that are needed would require 
extensions of those already developed—for example, tools for integrating -omics and 
clinical data. Although nanoinformatics is in its initial phase of development, the 
opportunities for computer specialists to contribute expertise and applications in nano-
medicine will be great. 
Several of the present authors have already carried out research on methods to auto-
matically extract information from the literature—primarily in bioinformatics [26] 
but also medical informatics1. We are now extending these efforts by working on an 
inventory of nano-resources, which would expand previous ones in the direction of 
nanoinformatics. Figure 2 shows a classical diagram reflecting the scope of biomedi-
cal informatics, with different research at various levels of granularity. We have added 
screenshots of our own three developments—for bioinformatics, medical informatics 
and nanoinformatics, related to each specific topic. 
2.5 Methods and tools to support research 
Over the past decade, a large number of significant initiatives have been launched— 
for example, the National Centers for Biomedical Computing (USA) and the Virtual 
Physiological Human (VPH) programme (Europe) [28]—for supporting biomedical 
engineering and informatics nationally and internationally. For instance, some of the 
authors' work has been within the context of the VPH, which supports a large number 
of projects addressing modeling and simulation of various systems, organs, tissues, 
and cells of the body, and their linking to clinical applications. Meanwhile, related 
efforts have been funded in the USA, usually with basic research objectives. Both 
approaches—clinical and basic research—can be highly complementary. Many engi-
neering approaches and tools that were developed for signal processing, imaging, 
modeling and simulation could be adapted in the future for nanoinformatics projects 
such as characterizing, modeling and simulating the behavior of nanoparticles used to 
target specific molecules within the body, or developing new imaging techniques using 
quantum dots for clinical research and practice, as mentioned above. Various reposito-
ries containing modeling and simulation tools are already available for nanotechnology 
De la Calle G, Nkumu-Mbomio N, Garcia-Remesal M, Maojo V. e-MIR2: tidying up medical informatics 
resources (in preparation). 
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Fig. 2 Examples of the automated tools developed by some of the authors at the UPM to address the 
automated creation of inventories of informatics resources—e.g., databases, software tools, services, etc. 
Screenshots of the applications developed at the UPM—from left to right, related to the inventories of 
resources for the nanoinformatics, bioinformatics and medical informatics fields—are linked to specific 
areas from Shortliffe's diagram of the various levels of biomedical informatics [27] 
applications (such as nanoHUB [29]) and can be expanded through adoption of com-
putational capability. In contrast, proprietary issues regarding nanoparticle design and 
development will add new issues to traditional computational approaches. The use 
of open source tools and data in nanoinformatics could also facilitate linkage in the 
future. An example of current facility, already available in the USA, is the cancer 
Nanotechnology Laboratory portal (caNanoLAB) [30]. Another initiative of interest, 
previously mentioned, is nanoHUB, a resource for nanoscience and technology created 
by the National Science Foundation-funded Network for Computational Nanotechnol-
ogy [29]. It includes applications, professional networking, and interactive simulation 
tools for nanotechnology. Similarly, some of the authors, at the University of Talca, in 
Chile, in collaboration with members of the Advanced Biomedical Computing Center 
at the NCI-Frederick, have developed a pilot database of nanoparticle structures, the 
Collaboratory for Structural Nanobiology (CSN) [31]. 
2.6 Education and training MI and BI professionals 
In the case of nanomedicine, the challenges and complexities of the field appear 
somewhat parallel, though possibly even more difficult than those that faced 
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Fig. 3 Nanoinformatics in the context of Medicine and related disciplines and fields 
bioinformaticians earlier in the context of the Human Genome Project. Education 
in nanomedicine and nanoinformatics requires adding content from areas such as 
advanced quantum physics and chemistry, including new models of imaging, multi-
scale modeling, and others. These new topics considerably extend past computational 
research and would add much to current curricula of medical schools. Professionals 
with expertise in nanoinformatics applications will have an important role as informa-
tion brokers, connecting people with diverse backgrounds. In such future academic 
programs for education in nanoinformatics and nanomedicine, informatics tools will 
play a decisive role for students and professionals by helping them to represent and 
manage the concepts and knowledge needed, without having to become quantum phys-
icists or chemists. Similarly, the latter can acquire knowledge about nanoinformatics 
to participate in research in the field. 
Figure 3 graphically depicts nanoinformatics as a related field to Medicine and 
other computer-related fields. 
3 Five significant areas of research where BMI should influence 
nanoinformatics 
We present below our ideas about Ave areas of research where the expertise and 
the lessons learned in the Human Genome and other -omics projects, the European 
Virtual Physiological Human programme, and projects related to basic and translational 
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Fig. 4 Five challenging areas for future nanoinformatics research 
research, may help develop nanoinformatics and its applications to nanomedicine. 
Since the number of topics can be very large, we have focused our attention on a few 
particularly significant challenges (see Fig. 4). 
3.1 Area 1: data, repositories and standards 
The most urgent need for a nanoinformatics infrastructure is to collect, curate, anno-
tate, organize and archive the available data. In addition to archiving the data, expert 
annotations and analysis regarding its quality and extent of validity, the infrastructure 
should allow for a federated system of public/private databases with adequate, layered 
access control to allow aggregation among public and private data where possible. 
The development or expansion of databases, software tools or repositories for nano-
particles, and, for example, their nanotoxicity, will allow the exchange of information 
about the actual 3-D structures of nanoparticles and nanomaterials and data about the 
physical and chemical properties of nanoparticles with biomedical applications. Since 
BMI professionals have built thousands of biomedical databases, their experience will 
be very valuable in building the required database infrastructure (Table 2). 
3.2 Area 2: interoperability: semantic search and ontologies 
An important need for nanoinformatics is to begin to federate the mostly isolated data 
silos that currently exist in different institutions. One example of such a federated 
system is caNanoLAB [30]. In this regard, semantic interoperability of heterogeneous 
information systems containing nano and other information will be a key issue in 
Table 2 Summary of challenges for Area 1 
• Creation of a Nanoinformatics infrastructure to collect, curate, annotate, organize and archive the 
available data 
• Design of extended web nana portals, linking groups and information around the world to facilitate data 
sharing 
• Development of repositories/databases of use cases, clinical trials experiments, databases and nano-
related informatics tools with nano-data, facilitating the reuse of the data—like Arrayexpress for genomic 
data. 
• Incorporation of regulatory aspects (standards, issues related to open data and source tools, quality 
control) 
Table 3 Summary of challenges for Area 2 
• Intercommunicate among different nanoportals, facilitating rapid sharing of data and other resources 
• Improve classification approaches by creating new hierarchies/taxonomies based on actual physical, 
chemical, biological, clinical, toxicological characteristics 
• Use cloud-computing services and supercomputers to carry out complex computational tasks, such as 
simulating interactions between nanoparticles and cells of the human body and supporting research in 
multiscale modeling. 
• Establish standards for reporting/publishing results in the nanoparticle/nanotechnology research 
literature. 
nanoinformatics, which will benefit from previous experiences [32]. Similarly, we 
have found in our early work on informatics methods for accessing the scientific lit-
erature related to nanomedicine that publications in the nano areas are ill structured, 
which makes information retrieval and extraction difficult. Improving the structure 
of abstracts and publications to facilitate such tasks has been already proposed in 
bioinformatics [33] (Table 3). 
A related challenge involves building classifications of nanoparticles. Such clas-
sification approaches could be very helpful in creating new hierarchies/taxonomies 
based on actual physical/chemical/clinical/toxic/spatial characteristics, and be sup-
plemented by detailed structural information as it becomes available. Some of the 
authors are currently working to develop new "morphospatial" taxonomies or ontol-
ogies [34], analyzing various examples from biomedical imaging, which can be also 
applied to nanoparticles. Current ontologies are based on different types of qualitative 
information and knowledge, but they cannot help in managing different, quantitative, 
visual/graphical types of information and knowledge that are included, for instance, 
in shapes, forms and volumes, such as those needed for nanoparticles. 
3.3 Area 3: extension of virtual integrative physiological programs 
BMI researchers have created a large number of models and simulation tools that could 
be reused or adapted to nanomedicine. For instance, 3-D representations and visualiza-
tions of molecular structures [35,36] which can be adapted to visualize nanoparticles. 
Adding significant information for understanding changes in the genotype induced 
by interactions with nanomaterials could possibly provide new foundations and 
Table 4 Summary of challenges for Area 3 
• Reuse the large number of models and simulation tools which have been created by BMI researchers to 
adapt them to nanomedicine. 
• Create a hypothetical, extended " nanotype" to allow cataloging of nanoparticles and their biological 
targets, their interactions in biological environments, their potential nanotoxicities and their relation to 
different diagnostic and therapeutic uses 
• Simulate "in silico" the effects, reactions or toxicity of new compounds or materials before "in vivo" 
studies and correlate both in silico and in vivo results to in vitro assay results. Multilevel simulations might 
predict effects of nanoparticles, provide better in vitro methods, and reduce the need for animal studies. 
• Initiate theoretical studies of the interactions between nanoparticles with the most common components 
of human cells 
Table 5 Summary of challenges for Area 4 
• Data and knowledge integration at the nano level, different to what has been already done between 
clinical and -omics data at larger scales. 
• The structural nature of nanomaterials and the unknown effects of many nanoparticles must be investigated 
independently of ontological analyses 
• Imaging. A key issue is to create new contrast agents to target specific organs, functions, or cell types 
and new imaging methods that are based on nanotechnogical advances 
explanations for phenotypical traits. A hypothetical "nanotype"—as we have named 
it—could include a large catalog of nanoparticles and biological targets, their inter-
actions, potential nanotoxicities and relations to different diagnostic and therapeutic 
medical uses. An example is provided by the Protein Data Bank (PDB) [37], which 
could be redesigned and extended to include nanotechnology applications (Table 4). 
3.4 Area 4: translational nanoinformatics 
Given that many molecular-level processes increasingly involve new atomic-level 
or nano-level measurements and understanding, bioinformaticians aims to carry out 
translational research to transform the increasing amount of -omics data into new 
knowledge that can provide, among other results, personalized medical diagnosis and 
therapy for patients by taking into account the complexity of multi-gene and envi-
ronmental interactions in human diseases. Similarly, nanomedicine requires novel 
insights beyond the current informatics technology that is typically focused on col-
lecting, representing and linking information that is usually heterogeneous. Another 
challenge would be to develop a nomenclature for nanomaterials. Analyzing structures 
and information at the nano level may require incorporating new assumptions beyond 
those considered in BMI (Table 5). 
Many current nanoinformatics applications look very similar—at least, on the sur-
face—to comparable systems already built. In this context, researchers begin to face 
unique challenges that nano brings to informatics as we have mentioned above, such 
as the polymorphic and polydispersed nature of nanomaterials and the as yet unknown 
effects of many nanoparticles. These variabilities imply a substantial added require-
ment for expert annotation and curation of data and analyses to inform scientists 
about the quality and reliability of the data, test methods, analyses and models used in 
nanomedicine. Establishing better methods for curation by digital means (e.g., wikis) 
Table 6 Summary of challenges for Area 5 
• To manage nanomedicine-related data. New standards will be needed for storing data, augmenting 
clinical vocabularies and terminologies or exchanging electronic medical information 
• Questions related to patient safety and possible secondary effects related to the use of nanoparticles need 
to be addressed and managed with nanoinformatics tools 
• The creation of large databases that would store nano-related information can be complemented by new 
approaches to building EHRs. It will require a collaborative effort from a number of researchers, including 
international initiatives—e.g., USA-Europe 
could provide another means of accessing literature and data. Such challenges need 
to be addressed prior to semantic or ontological analyses, and may well influence 
the new area of translational nanoinformatics, already proposed elsewhere [38]. That 
is, it will be used in defining the information needed to advance the science and the 
translation to clinical medicine. 
3.5 Area 5: linking nano information to the electronic health record (EHR) 
One of the clearest challenges of nanoinformatics is to link nanomedicine-related data 
to patient EHRs. Diagnostic and therapeutic methods based on new nanomaterials 
can enhance proposals for personalized medicine—mostly based on -omics advances. 
To manage the new, nano-related information—and create potential tools for helping 
with decision making—new models of EHRs must be developed (Table 6). 
To accomplish this, new extensions to current standards—such as SNOMED or 
HL7, for instance—, must be developed to incorporate nano-related information, ter-
minologies and procedures. Then, how can researchers extract useful clinical informa-
tion and predictive therapeutic rules from large sets of data obtained through clinical 
trials of therapeutics containing nanomaterials? How could a physician anticipate the 
possible therapeutic and toxic effects of nanoparticles for a specific patient? 
Despite their benefits, using nanoparticles for therapeutic purposes may involve 
hazards for patient safety due to their potential secondary effects, which are often 
reported in the literature. In this context, nanoinformatics methods and techniques 
can significantly contribute to automatically extracting and organizing the specific 
nanotoxicology information available in scientific papers, and make it available for 
clinicians and researchers. We have already conducted research along these lines, by 
applying text mining techniques to automatically identifying and extracting nano-
toxicology-related entities from the scientific articles2. This includes, for instance, 
names and types of nanoparticles—e.g. carbon nanotubes, fullerenes, etc.—, routes 
of exposure to the nanoparticles—e.g. inhalation, dermal contact, etc.—, potential 
targets—e.g. organs or anatomic locations—or toxic effects of nanoparticles such as 
destruction, inflammation, etc. The extracted information can be used for many dif-
ferent purposes, such as indexing and retrieving scientific papers with the different 
Garcia-Remesal M, Garcia-Ruiz A, Perez-Rey D, de la Iglesia D, Fritts M, Cachau R, Kulikowski CA, 
Maojo V (2011) Automatically extracting nanotoxicology-related entities from the literature (in prepara-
tion). 
entities appearing in them, automatically finding relationships between the detected 
entities, or automatically linking and aligning existing nanoinformatics and biomed-
ical ontologies. This kind of research actually addresses three of the five challenges 
suggested above: (1) data and knowledge storage and management, (2) nano-ontolo-
gies and semantic searches and (3) extending traditional Electronic Health Records to 
include nano-related information. 
4 Conclusions 
Various fundamental issues arise when analyzing this new field of nanoinformatics. 
These include, for instance, the large number of different computing applications that 
already emerge to cope with the different areas and topics of nanomedicine and nano-
technology, the large number of papers already indexed in bibliographic databases for 
nanotechnology and nanomedicine, the number of companies and nanotechnologists 
working with nanotechnological and nanomedical issues, the medical expectations of 
nanomedicine—promising to deliver breakthrough advances in various aspects of bio-
medicine—and the economic and ethical implications of this research. The growing 
importance of the field will lead professionals in the area to develop, in one way or 
another, the necessary nanoinformatics approaches. These will pose a wide range of 
new research challenges. 
By analyzing nanoinformatics, we can highlight various strong issues that involve 
building large databases, developing data and information standards, creating and 
mapping domain ontologies, linking related information (formerly, biological, and 
now, nano-related) to the computerized medical record, or assimilating new medical 
imaging techniques. In this regard, some unique scientific issues arise. 
The enormous challenges that nanotechnology and nanomedicine present require 
a significant investment to accelerate current research. Informatics requirements are 
similar to what was faced in the genomic and post-genomic research projects that 
transformed biomedicine. In this regard, the current activity of the authors, from three 
different continents, working together over the last 3 years in various nanoinformatics-
related research activities, illustrates the opportunities that international collaborations 
can provide to advance this new field. 
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